Get an in-depth insight of
one of the leading biotech investors
BB BIOTECH (SIX)
CHF 40.10
30.06.2024
Share Price Performance YTD
-2.0%
Market capitalisation
CHF 2.2 bn
Net Asset Value (NAV)
CHF 43.50
BB BIOTECH (XETRA)
EUR 41.60
30.06.2024
Share Price Performance YTD
-4.6%
Market capitalisation
EUR 2.3 bn
Net Asset Value (NAV)
EUR 45.20
Ionis Pharmaceuticals
13.0%
30.06.2024
Argenx SE
9.8%
30.06.2024
Neurocrine Biosciences
8.6%
30.06.2024
Vertex Pharmaceuticals
8.1%
30.06.2024
Alnylam Pharmaceuticals
7.3%
30.06.2024
Revolution Medicines
6.4%
30.06.2024
Moderna
6.1%
30.06.2024
Intra-Cellular Therapies
5.6%
30.06.2024
This website uses cookies, which are necessary for the technical operation of the website and which are always set. Other cookies to personalize content and analyze access to our website are only set with your consent. We also share information about your use of our website with our social media, advertising and analytics partners.
More info